RT Journal Article
SR Electronic
T1 Biometric covariates and outcome in COVID-19 patients: Are we looking close enough?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.04.20225961
DO 10.1101/2020.11.04.20225961
A1 Fritsch, Sebastian
A1 Sharafutdinov, Konstantin
A1 Marx, Gernot
A1 Schuppert, Andreas
A1 Bickenbach, Johannes
YR 2020
UL http://medrxiv.org/content/early/2020/11/06/2020.11.04.20225961.abstract
AB Background The impact of biometric covariates on risk for adverse outcomes of COVID-19 disease was assessed by numerous observational studies on unstratified cohorts, which show great heterogeneity. However, multilevel evaluations to find possible complex, e. g. non-monotonic multi-variate patterns reflecting mutual interference of parameters are missing. We used a more detailed, computational analysis to investigate the influence of biometric differences on mortality and disease evolution among severely ill COVID-19 patients.Methods We analyzed a group of COVID-19 patients requiring Intensive care unit (ICU) treatment. For further analysis, the study group was segmented into six subgroups according to BMI and age. To link the BMI/age derived subgroups with risk factors, we performed an enrichment analysis of diagnostic parameters and comorbidities. To suppress spurious patterns, multiple segmentations were analyzed and integrated into a consensus score for each analysis step.Results We analyzed 81 COVID-19 patients, of whom 67 required MV. Mean mortality was 35.8 %. We found a complex, non-monotonic interaction between age, BMI and mortality. A subcohort of patients with younger age and intermediate BMI exhibited a strongly reduced mortality risk (p < 0.001), while differences in all other groups were not significant. Univariate impacts of BMI or age on mortality were missing. Comparing MV with non-MV patients, we found an enrichment of baseline CRP, PCT and D-Dimers within the MV-group, but not when comparing survivors vs. non-survivors within the MV patient group.Conclusions The aim of this study was to get a more detailed insight into the influence of biometric covariates on the outcome of COVID-19 patients with high degree of severity. We found that survival in MV is affected by complex interactions of covariates differing to the reported covariates, which are hidden in generic, non-stratified studies on risk factors. Hence, our study suggests that a detailed, multivariate pattern analysis on larger patient cohorts reflecting the specific disease stages might reveal more specific patterns of risk factors supporting individually adapted treatment strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no external funding of this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis was approved by the local ethical review board (EK 091/20; Ethics Committee, Faculty of Medicine, RWTH Aachen, Aachen, Germany).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets of patients of University hospital RWTH Aachen, which were generated and analyzed during the current study, are not publicly available due to medical confidentiality but are available from the corresponding author on reasonable request.ARDSAcute respiratory distress syndromeBMIBody mass indexCOVID-19Corona virus disease 2019ECMOExtracorporeal membrane oxygenationICUIntensive care unitMVMechanical ventilationPCRPolymerase chain reactionPEEPPositive end expiratory pressureSARS-CoV2Severe acute respiratory syndrome Coronavirus 2